Dietary interventions target at reducing dietary saturated fatty acid and cholesterol to decrease the CVD risk. Currently, studies show that presence of excess adipose tissue seems to alter lipid and lipoprotein response to plasma cholesterol lowering diet. Diets low in SFA and dietary cholesterol are less efective in improving lipid profiles of obese individuals as compared to lean individuals. There are multiple mechanism which leads to altered response like decrease in LDL receptor activity, increased inflammation, abnormal function of enzymes involved in lipid metabolism and insulin resistance. Thus, normalizing adipose tissue mass is an important goal for maximizing the diet response to a plasma cholesterol-lowering diet.
INtRODuctION
Obesity is a well-defined epidemic in Westernized cultures and increasing prevalence is being seen in developing countries too. With obesity comes a variety of adverse health outcomes, such ashigh blood pressure, insulin resistance, and type 2 diabetes. Many lines of evidence have shown that chronic activation of proinflammatory pathways within insulin target cells can lead to obesity-related insulin resistance. Consistent with this, elevated levels of the proinflammatory cytokines TNFa, IL-6, and C-reactive protein (CRP) have been shown in individuals with insulin resistance and diabetes 1 Insulin resistance is defined as an inadequate response by insulin target tissues, such as skeletal muscle, liver, and adipose tissue,to the physiologic effects of circulating insulin. The hallmarks of impaired insulin sensitivity in these three tissues are decreased insulin-stimulated glucose uptake into skeletal muscle, impaired insulin-mediated inhibition of hepatic glucose production in liver, and a reduced ability of insulin to inhibit lipolysis in adipose tissue.In fact, insulin resistance is a major predictor for the development of various metabolic sequelae, including type 2 diabetes and is a defining feature of syndrome X, which is also known as the metabolic syndrome. This syndrome encompasses a constellation of conditions, including insulin resistance, dyslipidemia, hypertension, and obesity, and is often accompanied by hyperinsulinemia, sleep apnea, and other disorders 2 .MetS increases the risk developing CVD by 2-fold .Obesity (BMI > 30 kg/m2), which presents with dyslipidemia and elevated cholesterol levels, plays a major role in the development of MetS, which increases the risk of type II diabetes .Because of the exploding obesity epidemic, research efforts have escalated to better understand all aspects of the pathophysiology, including how obesity affects lipid and lipoprotein metabolism.
Numerous factors affect variability in lipid response to diet.Greater cholesterol synthesis and lower cholesterol absorption can arise as a consequence of insulin resistance, often causing a diminished plasma lipid response to diet 3 Dietary interventions are effective for improving the lipid and lipoprotein profile. Replacing SFA with MUFA, PUFA, and/or carbohydrate (CHO) reduces LDL cholesterol (LDL-C) 4,5. A mechanism by which replacing SFA with PUFA lowers LDL-C is via an increase in LDL receptor(LDLR)-mediated uptake of LDL-C from circulation .LDLR-mediated uptake, however, is impaired by obesity 6 . Consequently, obese individuals are less responsive to dietary interventions aimed at improving the lipid/lipoprotein profile. A greater understanding of the factors that diminish lipid uptake in obese individuals likely will increase understanding of why they have a blunted lipid response to dietary interventions.
The purpose of this review is to summarize the evidence and discuss the possible mechanisms that contribute to the blunted lipid response to dietary change that is associated with obesity. This review will discuss the effects of dietary SFA and cholesterol on changes in plasma lipids and lipoproteins and the effect of adiposity on these responses. However endocrine disregulation is beyond the scope of this review
Obesity causes A blunted Lipid Response to sFA And cholesterol In the Diet
A number of clinical studies have shown an inverse relation between BMI and lipid response. The lipid and lipoprotein response is greater in lean individuals compared to obese. BronsgeestSchoute et al. included participants who typically consumed at leat 1 egg/d. They were not allowed to consume any egg products for three weeks. The experimental diet consisted of 264mg/d cholesterol and their daily diet consisted of 742mg/d. A small but significant decrease in total cholesterol (TC) was reported (-0.16 ± 0.40 mmol/L; P < 0.05) with an inverse correlation (r = -0.321; P < 0.05) between BMI and the reduction in TC. When participants were classified on the basis of BMI, only those who were not obese had a reduction in TC (-0.23 ± 0.43 mmol/L; P < 0.01. A study done by Mukuddem-Petersen et al. reported no lipid/lipoprotein effects of a weight maintenance diet that contained either walnuts or cashews (20% of energy came from nuts) in obese individuals. The study showed that the benefit of nut consumption was not seen in obese individuals having metabolic syndrome . 8 Lefevre et al did a randomized, doubleblind, 3-period crossover controlled feeding design to examine the effects on plasma lipids of 3 diets that differed in total fat: the average American diet (AAD) [designed to contain 38% fat and 14% saturated fatty acids (SFAs)], the Step I diet (30% fat with 9% SFAs), and the Step II diet (25% fat with 6% SFAs). The diets were fed for 6 wk each to 86 free-living, healthy men aged 22-64 y at levels designed to maintain weight. This study showed that persons who are insulin resistant respond less favorably to
Step II diets than do those who are insulin sensitive. The data suggested that even in the absence of overt metabolic syndrome, weight reduction may be required to fully derive the benefit of dietary changes on CVD risk. A study done by Jansen et al, aimed at establishing whether being overweight is a factor whoch determines individuals response to dietary lipid changes. Forty-one non-obese healthy men were divided into two groups according to body mass index as follows: controls, <25 kg/m 2 ; overweight, >25 kg/m 2 but <30 kg/m 2 . After consuming a saturated fat-rich diet (SAT diet: 38% fat, 20% saturated) for 4 wk, subjects were switched to a low fat diet [National Cholesterol Education Program (NCEP)-I diet: 28% fat, 10% saturated] for 4 wk and then to a monounsaturated fat-rich diet (MUFA diet: 38% fat, 22% monounsaturated) for 4 wk. Plasma cholesterol concentrations changed to a lesser extent, and triglyceride concentration to a greater extent, in overweight but non-obese young men than in those of normal weight in response to changes in dietary fat composition. The data suggest that in the diet treatment of obese hyperlipemic subjects, it is more important for them to lose weight than to change the fat composition of their diets 10 From the above studies it is seen that body weight is an important predictor of response to changes in diet quality of individuals. The plasma cholesterol lowering effect of low SFA and cholesterol diet was more in lean individuals as compared to obese individuals
Adipose tissue Induced Inflammation
E x c e s s a d i p o s e t i s s u e r e s u l t s i n inflammation that leads to insulin resistance. The increase in adipocyte size and ensuing expansion of adipose tissue mass increases FFA release into the circulation and decreases oxygen delivery to the cells 2 . This leads to an increase in cellular stress, adipocyte death, and expression of inflammatory genes, enhancing the activation of the proinflammatory c-Jun N-terminal kinase 1 (JNK1) and inhibitor of kappaB kinase (IKK)/ NF-kB pathways 11 . Macrophages accumulate in the adipose tissue and remodel the tissue (2) . Additional proinflammatory cytokines (TNFa and IL-6) and chemokines are released, which can initiate the JNK1 and IKK/NF-kB pathways in nearby adipocytes, causing further macrophage recruitment to local sites of injury, or circulate to the liver and initiate a similar process. Adipocytes also secrete a variety of adipokines, many of which affect insulin sensitivity. For instance, leptin and adiponectin have been shown to promote insulin sensitivity, whereas resistin and retinol-binding protein 4 interfere with insulin action and diminish insulin sensitivity. Eventually, an inflammatory environment in insulin target cells, specifically adipocytes and hepatocytes, causes localized insulin resistance due to stimulation of adipocyte lipolysis and complications associated with the inflammatory response, including reduced adiponectin, increased resistin, and increased hepatic glucose production 2 .
The proinflammatory cytokine TNFá can contribute independently to insulin resistance by reducing insulin receptor expression, insulin receptor substrate and GLUT4 gene expression, adiponectin, hormone sensitive lipase, and insulin-mediated glucose uptake 12, 13 . CRP is synthesized and secreted by the liver in response to proinflammatory cytokines, specifically IL-6.TNFa, IL-6, and CRP typically are elevated in insulin-resistant states 14 . Human serum paraoxonase 1 (PON1) is an enzyme with esterase activity, and is physically bound to highdensity lipoproteins (HDL). It plays a key role in the action of HDL toward protection of lipoprotein and biological membrane against oxidative damage In obese adults, diminished levels of PON1 activity is correlated with low levels of HDL cholesterol 15 In an obese individual, lipid also can accumulate in the muscle and liver independent of adipocyte lipolysis, initiating a proinflammatory state and the development of insulin resistance. Inflammation has been demonstrated to impair reverse cholesterol transport (RCT) at various steps in the pathway, conserving cholesterol stores in the body and preventing cholesterol flux through liver to bile and feces 16 . The inhibition of RCT likely contributes to insulin resistance and MetS, negatively altering the lipid profile and potentially accelerating the development of CVD.
The key point is that excess adipose tissue and nutrient intake causes an increase in inflammation, which leads to the development of insulin resistance and the ensuing decrease in lipid response to changes in dietary SFA and cholesterol.
Obesity, tissue Inflammation, And Insulin Resistance
Nutrient excess, weight gain, and ensuing obesity result in expansion of adipose tissue mass and adipocyte size. With this expansion, total free fatty acid release into the circulation is increased and oxygen delivery to the adipocyte is decreased. The combination of microhypoxia and nutrient excess leads to induction of Hypoxia inducible factor-1 HIF-1 and the downstream target genes as well as endoplasmic reticulum (ER) stress within the adipocyte. This can lead to the eventual death of the adipocyte as well as a characteristic inflammatory response. The inflammatory response includes increased production and release of proinflammatory cytokines/chemokines and the recruitment of bone marrow-derived macrophages. These macrophages are of the M1 activation/polarization state and are highly inflammatory in nature. Once recruited, these macrophages release proinflammatory cytokines, which work in a paracrine manner to activate the intracellular proinflammatory pathways (e.g., JNK and IKK) in neighboring cells and possibly through endocrine mechanisms in distal tissues. In a feed-forward cycle, activation of macrophages promotes the recruitment and infiltration of additional macrophages into adipose tissue. This results in cell autonomous insulin resistance in adipocytes and liver, exacerbation of the inflammatory state, and systemic insulin resistance. With obesity, there is also increased fat accumulation within skeletal muscle, and these intermuscular fat depots becomes infiltrated with proinflammatory macrophages, which may cause paracrine-like insulin resistance in skeletal muscle. In parallel with these inflammation-related changes, alterations in fatty acid metabolism can lead to the accumulation of fatty acid intermediates with the liver and skeletal muscle, which can cause insulin resistance. (Figure-1 Insulin resistance or elevated insulin concentrations directly lead to metabolic changes in the hepatocyte that result in diminished responsiveness of the hepatic LDL-cholesterol receptor to changes in dietary fatty acids. This occurs through a mechanism whereby elevated insulin concentrations directly increase hepatic cholesterol synthesis through activation of the liver X receptor. Secondary to the elevated endogenous production of cholesterol, hepatic LDL-cholesterol receptors would be expected to be down-regulated and therefore refractory to additional reductions in LDL cholesterol that are typically associated with dietary changes 17. LXRs have been proposed to act as sterol sensors that function to help the organism adapt so it can cope with the effects of high free cholesterol levels in blood 18 . The activity of lipoprotein lipase (LPL) is an important first step in plasma triglyceride clearance and FFA delivery to the adipocyte, particularly in the postprandial state. Insulin and glucose have been shown to stimulate adipose tissue LPL activity and to reduce LPL activity in muscle, implying a preferential postprandial partitioning of lipoprotein-derived fatty acids toward adipose tissue and away from muscle. In obesity and type 2 diabetes, insulin activation of LPL in adipose tissue is delayed, and LPL activity in skeletal muscle is increased instead of decreased by hyperinsulinemia. The importance of LPL in tissue FFA uptake has recently been demonstrated by experiments in which either muscle-specific or liver-specific overexpression in mice induces marked tissue lipid accumulation 19 . Although LPL may be viewed as a first step leading to the uptake of FFA by adipose tissue, it is clear that the deposition of FFA is also regulated downstream of LPL. Thus in the presence of insulin resistance, LDLR activity is blunted and LDL binding declines, resulting in impaired receptor-mediated LDL-C removal and decreased chylomicron remnant clearance 17 . The decrease in LDL-C uptake leads to an increase in endogenous cholesterol production, perhaps by the stimulation of LXRá. Hyperinsulinemia has been shown to stimulate LXRá which is known to regulate lipogenesis and cholesterol excretion. However, it is possible that decreased cholesterol absorption is secondary to increased cholesterol synthesis. Both states are related to insulin resistance; therefore, concurrent changes in both cholesterol absorption and synthesis make it difficult to determine which state is affected primarily by insulin resistance. Greater cholesterol production likely would lead to a further decline in LDLR activity and, consequently, a resistance to reductions in LDL-C that are associated with dietary fat and cholesterol modifications 20 ATP-binding cassette (ABC) transporters, Abcg5 and Abcg8 are expressed predominantly in the liver and small intestine and are coordinately up-regulated at the transcriptional level by dietary cholesterol. The response of Abcg5 and Abcg8 to cholesterol requires the liver X receptor a (LXRa) .Disruption of insulin signaling and stimulation of the LXRa pathway increases the expression of intestinal, specifically ABCG5 and ABCG8 21 . ABCG5 and ABCG8 regulate the secretion of cholesterol and sterols from intestinal enterocytes into the intestinal lumen and from hepatocytes into the biliary space 22 . Therefore, upregulation of ABCG5 and ABCG8 promotes biliary cholesterol secretion and decreased cholesterol absorption, which leads to the increase in hepatic cholesterol synthesis 23. High-cholesterol and high-fat diets also have been shown to increase the mRNA of ABCG5 and ABCG8. Subtle defects in these proteins or in their regulation may underlie the variable responses of healthy individuals to high-cholesterol diet 24 . In addition, single nucleotide polymorphisms in the ABCG5 and ABCG8 genes can alter cholesterol metabolism and various lipid responses 25 . Thus, ABCG5 and ABCG8 are important factors to consider in regulating endogenous cholesterol homeostasis. Hyperinsulinemia enhances expression of the ABCG5 and ABCG8 genes, stimulating cholesterol excretion and decreasing cholesterol absorption. However, proinflammatory cytokines, IL-6 and TNFa, as well as insulin, have been shown to inhibit CYP7A1 gene transcription, thereby decreasing bile acid synthesis as an adaptive response to protect hepatocytes from injury.Evidence suggests that these cell-signaling pathways crosstalk to regulate bile acid synthesis to maintain hepatic bile acid homeostasis 26 Insulin resistance initiated by adipose tissue-induced inflammation leads to increased cholesterol synthesis and decreased cholesterol absorption
Hypocaloric Diets And Lipid Response Lipid Response In Obese Individuals
The lipid and lipoprotein response is greater in obese individuals following weight loss. (27) (28) (29) (30) (31) Following are a few selected studies which have reported that hypocaloric diet in addition to weight loss also have improved the lipid profile in obese and overweight individuals.
cONcLusION
Obese individuals show a blunted lipid response in response to cholesterol lowering diets. These cholesterol lowering diets do not favourably modify the plasma lipid and lipoproteinin obese individuals. As there is decreased cholesterol excretion and increased cholesterol synthesis which is a result of insulin resistance and inflammation commonly seen in obesity.There is also alteration in the activity of enzymes involved in normal lipid metabolism (eg. LPL) which in turn leads to differential response to change in dietary lipid. On the contrary, a reduction in adipose tissue mass enchances LDL receptor activity by decreasing insulin resistance and inflammation. As a result, weight loss is recommended for overweight/obese individuals to realize the maximal benefits of dietary interventions low in SFA and cholesterol. Hypocaloric diets (500 kcal less from requirement) which bring about weight loss in obese individual have shown to have dual benefit of improving the lipid profile as well. Therefore, in conclusion it can be said that bringing about weight loss first and then improving the lipid profile should be considered while planning dietary interventions.
